Azenta Future Growth
Future criteria checks 0/6
Azenta is forecast to grow earnings and revenue by 83.8% and 7% per annum respectively. EPS is expected to grow by 80.3% per annum. Return on equity is forecast to be -0.6% in 3 years.
Key information
83.8%
Earnings growth rate
80.3%
EPS growth rate
Life Sciences earnings growth | 16.8% |
Revenue growth rate | 7.0% |
Future return on equity | -0.6% |
Analyst coverage | Good |
Last updated | 14 May 2024 |
Recent future growth updates
Recent updates
Should You Investigate Azenta, Inc. (NASDAQ:AZTA) At US$52.18?
Apr 27Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price
Apr 05Subdued Growth No Barrier To Azenta, Inc.'s (NASDAQ:AZTA) Price
Dec 28Is There An Opportunity With Azenta, Inc.'s (NASDAQ:AZTA) 31% Undervaluation?
Nov 07At US$50.66, Is It Time To Put Azenta, Inc. (NASDAQ:AZTA) On Your Watch List?
Sep 13Estimating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA)
Aug 09Is Azenta, Inc. (NASDAQ:AZTA) Potentially Undervalued?
Jun 01Revenue Downgrade: Here's What Analysts Forecast For Azenta, Inc. (NASDAQ:AZTA)
May 11Is Azenta, Inc. (NASDAQ:AZTA) Worth US$42.5 Based On Its Intrinsic Value?
Mar 30Azenta: Putting Its Cash Hoard To Use
Oct 02Azenta to acquire vaccine cold chain firm B Medical Systems for €410M
Aug 08Brasada Capital - Azenta Life Sciences: No Ordinary Company
Jul 26Azenta stock falls postmarket as prelim Q3 revenue misses Street estimates
Jul 13Calculating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA)
May 05Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2026 | 773 | 3 | 28 | 98 | 5 |
9/30/2025 | 713 | -31 | 0 | 69 | 6 |
9/30/2024 | 663 | -124 | -102 | -57 | 6 |
3/31/2024 | 652 | -152 | 55 | 91 | N/A |
12/31/2023 | 641 | -17 | 32 | 71 | N/A |
9/30/2023 | 665 | -13 | -22 | 17 | N/A |
6/30/2023 | 630 | -21 | -56 | -13 | N/A |
3/31/2023 | 597 | -26 | -500 | -449 | N/A |
12/31/2022 | 594 | -25 | -581 | -509 | N/A |
9/30/2022 | 555 | -11 | -543 | -466 | N/A |
6/30/2022 | 555 | -28 | -530 | -449 | N/A |
3/31/2022 | 551 | -23 | -59 | 16 | N/A |
12/31/2021 | 535 | -29 | 66 | 122 | N/A |
9/30/2021 | 514 | -29 | 97 | 150 | N/A |
6/30/2021 | 114 | -69 | 130 | 175 | N/A |
3/31/2021 | 205 | -53 | 112 | 156 | N/A |
12/31/2020 | 296 | -37 | 10 | 56 | N/A |
9/30/2020 | 389 | -26 | -2 | 38 | N/A |
6/30/2020 | 850 | 41 | -19 | 19 | N/A |
3/31/2020 | 834 | 28 | -7 | 29 | N/A |
12/31/2019 | 812 | 16 | 80 | 110 | N/A |
9/30/2019 | 334 | -61 | 67 | 91 | N/A |
6/30/2019 | 741 | 3 | 70 | 89 | N/A |
3/31/2019 | 710 | 7 | 56 | 73 | N/A |
12/31/2018 | 668 | 72 | 63 | 77 | N/A |
9/30/2018 | 632 | 68 | 61 | 74 | N/A |
6/30/2018 | 488 | 35 | 62 | 78 | N/A |
3/31/2018 | 498 | 47 | 63 | 76 | N/A |
12/31/2017 | 510 | -2 | N/A | 81 | N/A |
9/30/2017 | 527 | 11 | N/A | 96 | N/A |
6/30/2017 | 669 | 56 | N/A | 85 | N/A |
3/31/2017 | 634 | 47 | N/A | 82 | N/A |
12/31/2016 | 600 | -51 | N/A | 71 | N/A |
9/30/2016 | 434 | -85 | N/A | 40 | N/A |
6/30/2016 | 549 | -73 | N/A | 38 | N/A |
3/31/2016 | 546 | -74 | N/A | 39 | N/A |
12/31/2015 | 550 | 12 | N/A | 28 | N/A |
9/30/2015 | 553 | 14 | N/A | 44 | N/A |
6/30/2015 | 529 | 8 | N/A | 35 | N/A |
3/31/2015 | 502 | -3 | N/A | 23 | N/A |
12/31/2014 | 489 | -3 | N/A | 48 | N/A |
9/30/2014 | 483 | 1 | N/A | 54 | N/A |
6/30/2014 | 471 | 3 | N/A | 65 | N/A |
3/31/2014 | 464 | 10 | N/A | 73 | N/A |
12/31/2013 | 448 | 5 | N/A | 58 | N/A |
9/30/2013 | 422 | -7 | N/A | 54 | N/A |
6/30/2013 | 431 | 107 | N/A | 33 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AZTA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AZTA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AZTA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AZTA's revenue (7% per year) is forecast to grow slower than the US market (8.4% per year).
High Growth Revenue: AZTA's revenue (7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AZTA is forecast to be unprofitable in 3 years.